SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?


To: Dav!d who wrote (6514)5/7/2014 9:25:35 AM
From: Dav!dRespond to of 202400
 
NB. Got lucky with my sell. I am looking to buy back at $0.55. They will probably announce news on drilling. But we will have awhile before there is any substantial news to drive the stock price higher.
Just my opinion.

Pre-market bids/ask @ $0.66. Last close at $0.70.

David.



To: Dav!d who wrote (6514)4/23/2018 8:05:06 AM
From: Goose94Read Replies (2) | Respond to of 202400
 
Knight Therapeutics (GUD-T) Mackie Research defensive play due to its strong balance sheet. Hold rating and our target price of $7.90 NR Apr 20, '18 Canadian Regulatory Approval for PROBUPHINEâ„¢ for Opioid Drug Dependence web.tmxmoney.com